What is Tanner Foundation?
The Tanner Foundation for Neurological Diseases operates as a pivotal entity in the healthcare landscape, specifically targeting the unmet needs of individuals affected by Multiple Sclerosis, ALS, and Parkinson's disease. By integrating direct patient assistance with high-impact research funding, the organization serves as a vital conduit for community health resources. Its market position is defined by a dual-focus strategy: providing immediate relief to patients while simultaneously underwriting the scientific advancements necessary to address the long-term challenges of neurodegenerative disorders. This hybrid model of service and advocacy ensures that the foundation remains a cornerstone for community-based neurological support.
How much funding has Tanner Foundation raised?
Tanner Foundation has raised a total of $30K across 1 funding round:
Debt
$30K
Debt (2021): $30K with participation from PPP
Key Investors in Tanner Foundation
PPP
Public-Private Partnership
What's next for Tanner Foundation?
With the recent influx of capital, the Tanner Foundation is poised to scale its operational capacity and broaden its research portfolio. The strategic roadmap likely involves expanding the reach of its patient assistance programs and deepening its investment in clinical trials that offer the most promise for therapeutic breakthroughs. As the organization matures through this growth phase, the focus will shift toward optimizing resource allocation to maximize the efficacy of its research grants. By maintaining a disciplined approach to capital deployment, the foundation aims to solidify its influence in the neurological health space, ensuring that its educational and support services remain accessible to an increasingly diverse patient population.
See full Tanner Foundation company page
